DE1525541U - - Google Patents

Info

Publication number
DE1525541U
DE1525541U DENDAT1525541D DE1525541DU DE1525541U DE 1525541 U DE1525541 U DE 1525541U DE NDAT1525541 D DENDAT1525541 D DE NDAT1525541D DE 1525541D U DE1525541D U DE 1525541DU DE 1525541 U DE1525541 U DE 1525541U
Authority
DE
Germany
Prior art keywords
iwt
dwr
becomes
bwi
diw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1525541D
Other languages
German (de)
English (en)
Publication of DE1525541U publication Critical patent/DE1525541U/de
Active legal-status Critical Current

Links

Landscapes

  • Developing Agents For Electrophotography (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1525541D Active DE1525541U (enExample)

Publications (1)

Publication Number Publication Date
DE1525541U true DE1525541U (enExample)

Family

ID=826748

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1525541D Active DE1525541U (enExample)

Country Status (1)

Country Link
DE (1) DE1525541U (enExample)

Similar Documents

Publication Publication Date Title
Kaku et al. Efficacy and safety of fasiglifam (TAK‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial
Wolff et al. Drug-induced diabetes: diabetogenic activity of long-term administration of benzothiadiazines
CN100522080C (zh) 外科夹具推进和对准机构
Chesney Adherence to HAART regimens
Eaton et al. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies
Campbell et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features
Hoenig et al. The nosological position of transsexualism
NO20041941L (no) Doseringsform, utstyr og fremgangsmater for behandling
Rose et al. Intravenous dexamethasone‐cyclophosphamide pulse therapy in comparison with oral methylprednisolone‐azathioprine therapy in patients with pemphigus: Results of a multicenter prospectively randomized study: Intravenöse Dexamethason‐Cyclophosphamid‐Pulstherapie im Vergleich zu einer oralen Methylprednisolon‐Azathioprin‐Therapie bei Patienten mit Pemphigus‐Erkrankungen: Ergebnisse einer multizentrischen, prospektiven, randomisierten Studie
DE1525541U (enExample)
World Health Organization Chemotherapy of leprosy: report of a WHO study group [meeting held in Geneva from 1 to 5 November 1993]
Groop et al. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Maibach Glutaraldehyde: cross-reactions to formaldehyde?
Powers et al. Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys
Mackay et al. Failure of lithium treatment in established tardive dyskinesia
Conway et al. A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective
Merson The global problem of acute diarrheal diseases and the WHO Diarrheal Diseases Control Programme
Niang et al. Controlled Trial of 3-Day
Pettigiani The Meaning of the Female Presence in Messianic Texts within the Corpus of the Nevi’im
Knepr The role of public health in emergency situations
Lamberti Omotic and Cushitic. A Reply to Fleming
Leroy et al. 272-PA12 Survival of HIV-infected patients after tuberculosis, Bordeaux, France, 1988–1994
COHEN Ground AIDS Zero: Research in Africa
Bruyn Study regimen changes
Olliaro et al. Miltefosine in visceral leishmaniasis